Shockwave Medical
Shockwave Medical, part of Johnson & Johnson MedTech, is a leader in the development and commercialization of innovative products that are transforming the treatment of cardiovascular disease. Its first-of-its-kind Intravascular Lithotripsy (IVL) technology has transformed the treatment of atherosclerotic cardiovascular disease by using sonic pressure waves to disrupt challenging calcified plaque, resulting in significantly improved patient outcomes. Its Reducer technology, which is under clinical investigation in the United States and is CE Marked in the European Union and the United Kingdom, is designed to provide relief to the millions of patients worldwide suffering from refractory angina by redistributing blood flow within the heart. Learn more at www.shockwavemedical.com.
PREDICTABLY SAFE – Safely modify calcium while significantly reducing the risk of complications to make procedures more predictable and efficient
DISTINCTLY INTUITIVE – Simplify the treatment of calcium from the very first case via a unique MOA on an intuitive platform
CONSISTENTLY EFFECTIVE – Proven to achieve low residual stenosis across multiple vessel beds by disrupting superficial and deep calcium
Shockwave Important Safety Information: https://shockwavemedical.com/important-safety-information-universal/
